Investors - Press Releases
Tabula Rasa HealthCare Launches MedWise™ SaaS Technology Integration for Community Pharmacists
“If a person takes seven or more medications, which is common among the elderly, the chance of experiencing an adverse drug event (ADE) is 82%,” said TRHC Chairman and CEO
Available within TRHC’s PrescribeWellness patient engagement software, MedWise includes the unique MedWise Risk Score™ (MRS) calculation along with a new feature known as MedWise Decision Support (MDS). MDS simulates changes to the risk score in real-time, helping pharmacists to assess simultaneous, accumulative, multi-drug interactions amongst complex medication regimens in an efficient manner and avoid ADEs. ADEs are largely considered preventable and are the third leading cause of death.
“Through MedWise, we're helping to provide significantly enhanced clinical services and improved outcomes for our patients,” said PrescribeWellness client
“Community pharmacists have at their disposal an unprecedented opportunity for risk mitigation and clinical intervention utilizing MedWise, available within the PrescribeWellness software," said TRHC EVP of PW,
While client-reported data has existed for years, recently published studies found that reduction in the MRS is associated with lower medical costs, fewer adverse drug events, emergency department visits, and hospitalizations.
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
TRHC’s PrescribeWellness solution is a leading cloud-based patient relationship management technology that facilitates collaboration between more than 10,000 pharmacies, payers, providers, pharmaceutical companies and their patients for better health. Visit https://www.prescribewellness.com/ or https://www.tabularasahealthcare.com/our-solutions/technology-products/.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
|TRHC Media Contact
T: (215) 870-0829
|TRHC Investor Contact
T: (866) 648-2767
T: (856) 912-5714
Source: Tabula Rasa HealthCare, Inc.